Figure 7From: Antidiabetic, antioxidant, antihyperlipidemic effect of extract of Euryale ferox salisb. with enhanced histopathology of pancreas, liver and kidney in streptozotocin induced diabetic ratsEffect of EFx on various antioxidant marker enzymes at the end of therapy, Group 1: normal control; Group 2: STZ (60 mg/kg i.p.); Group 3: diabetic control + (EFx) (100 mg/kg body weight); Group 4: diabetic control + (EFx) (200 mg/kg body weight) and continue for 45 days; Group5: diabetic + diabetic control + (EFx) (300 mg/kg body weight) and continue for 45 days; Group 6: diabetic control + (EFx) (400 mg/kg body weight) and continue for 45 days; Group 7: diabetic control + glibenclamide (1 mg/kg body weight) and continue for 45 days.Back to article page